LOG IN
SIGN UP
MARKET
EKSO
EKSO
Ekso Bionics
NASDAQ
1.470
+0.197
+15.51%
After Hours: 1.430 -0.04 -2.72% 17:56 12/08 EST
OPEN
1.320
PREV CLOSE
1.273
HIGH
1.490
LOW
1.300
VOLUME
211.71K
TURNOVER
0
52 WEEK HIGH
3.490
52 WEEK LOW
1.030
MARKET CAP
19.32M
P/E (TTM)
-1.2463
1D
5D
1M
3M
1Y
5Y
BRIEF-Ekso Bionics Announces Acquisition Of Human Motion, Control Business Unit Including Indego Product Line From Parker Hannifin Corp
Reuters · 3d ago
Ekso Bionics Announces Acquisition Of Human Motion and Control Business Unit Including Indego Product Line From Parker Hannifin Corporation For An Aggregate Purchase Price Of $10M
Benzinga · 3d ago
Ekso Bionics (EKSO) Reports Q3 Loss, Lags Revenue Estimates
Ekso Bionics (EKSO) delivered earnings and revenue surprises of -37.50% and 7.01%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Zacks · 11/03 22:05
Ekso Bionics Holdings GAAP EPS of -$0.33, revenue of $3.3M
Seekingalpha · 11/03 20:28
Ekso Bionics Reports Third Quarter 2022 Results
Quarterly Record of 33 EksoNR Bookings in Q3 2022 SAN RAFAEL, Calif., Nov. 03, 2022 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company”), an industry leader in exoskeleton technology for medical and industrial use, today reported ...
GlobeNewswire · 11/03 20:05
-- Earnings Flash (EKSO) EKSO BIONICS HOLDINGS Reports Q3 Revenue $3.3M
-- Earnings Flash (EKSO) EKSO BIONICS HOLDINGS Reports Q3 Revenue $3.3M
MT Newswires · 11/03 16:29
Preview: Ekso Bionics Holdings's Earnings
Benzinga · 11/02 16:15
BRIEF-Ekso Bionics Holdings Inc Board Of Directors Approved Jerome Wong As Chief Financial Officer On Oct. 26
Reuters · 10/31 10:39
About EKSO
Ekso Bionics Holdings, Inc. designs, develops, sells, and rents exoskeleton products that augment human strength, endurance and mobility. The Company’s exoskeleton technology serves multiple markets and can be utilized both by able-bodied users and persons with physical disabilities. The Company operates in two segments: EksoHealth and EksoWorks. The EksoHealth segment designs, engineers, manufactures, and markets exoskeletons for applications in the medical markets. The EksoWorks segment designs, engineers, manufactures, and markets exoskeleton devices to allow able-bodied users to perform repetitive work. Its products include EksoNR and EksoUE. EksoNR is a rehabilitation device that assists physical therapists and physicians to treat patients who have suffered an acquired brain injury, stroke or spinal cord injury. EksoUE is a wearable upper body exoskeleton that assists patients with a broad range of upper extremity impairments.
Webull offers kinds of Ekso Bionics Holdings Inc stock information, including NASDAQ:EKSO real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, EKSO stock news, and many more online research tools to help you make informed decisions.
You can practice and explore trading EKSO stock methods without spending real money on the virtual paper trading platform.